Theme II – Predictive Toxicology

Coordinators

Nathalie Alépée, L’Oréal, Aulnay-sous-Bois, France
Kevin Crofton, US EPA, Research Triangle Park, NC, USA
Rodger Curren, IIVS, Gaithersburg, MD, USA
Carl Westmoreland, Unilever, Sharnbrook, UK

II-1a   Pathways approaches in toxicology
Kim Boekelheide, Brown University, USA
Maurice Whelan, EURL ECVAM, JRC, Italy

II-1b   Pathways approaches in toxicology
Katie Paul, Bayer CropScience, USA
Mathieu Vinken, Vrije Universiteit Brussel, Belgium

II-1c   Pathways approaches in toxicology
Ralf Herwig, MPI Molecular Genetics, Germany
Lena Smirnova, CAAT, USA

II-2     Systems biology
Ralf Herwig, MPI Molecular Genetics, Germany
Richard Judson, U.S. EPA, USA

II-3     Computational modeling and chem-informatics
Makoto Hayashi, BSRC, Japan
Ann Richard, EPA, USA

II-4a   Risk Assessment – Nano
Harvey Clewell, The Hamner Institutes for Health Sciences, USA
Keith Houck, US EPA, USA

II-4b   Risk Assessment – Cosmetics
Vera Rogiers, Vrije U. Brussels, Belgium
Carl Westmoreland, Unilever, UK

II-5     Discussion session: Application in decision making and testing strategies
Silke Gabbert, Wageningen University, The Netherlands
Joanna Jaworska, P&G, Belgium

II-6a   Updates on Research Activities from the USA
Russell Thomas, EPA, USA
Ray Tice, NIEHS, USA

II-6b   Updates on Activities from Japan
Yoshihiro Ohmiya, AIST, Japan
Noriho Tanaka, HATANO, Japan

II-7     Update from Europe – Alternative testing strategies program
Catherine Mahony, Procter & Gamble, UK
Horst Spielmann, FU Berlin, Germany

II-8     Meeting new regulatory challenges following the cosmetic ingredients ban – Cosmetics Europe’s research programme on alternatives
Patric Amcoff, Cosmetics Europe, Belgium
Horst Wenck, SCT AAT & Beiersdorf, Germany

II-9     Exposure
Robert Landsiedel, BASF, Germany
John Wambaugh, EPA, USA

II-10a Topical toxicity – Skin
Nathalie Alépée, L’Oreal, France
Helena Kandarova, SETOX/MatTek, Slovakia

II-10b Topical toxicity – Eye
João Barroso, EURL-ECVAM, Italy
Pauline McNamee, Procter & Gamble, UK

II-10c Topical toxicity – Phototox
Abigail Jacobs, USFDA, USA
Manfred Liebsch, Foundation SET, Germany

II-11   Repeated dose toxicity
Gladys Ouédraogo, L’Oreal, France
Michael Schwarz, University of Tübingen, Germany

II-12a Skin sensitization
Gavin Maxwell, Unilever, UK
Tzutzuy Ramirez, BASF, Germany

II-12b Skin sensitization
João Barroso, EURL-ECVAM, Italy
Andreas Natsch, Givaudan Schweiz AG, Duebendorf, Switzerland

II-13   Endocrine disruption
David Dix, EPA, USA
Jean-Lou C. M. Dorne, EFSA, Italy

II-14   Reproductive & developmental toxicology
George Daston, Procter& Gamble, USA
Koichi Saito, Sumitomo Chemical Co., Japan

II-15   Genotoxicity/Carcinogenicity
Rolf Fautz, KAO Europe, Germany
David Kirkland, Kirkland Consulting, UK

II-16a Inhalation toxicology – Nano
Marianne Geiser, University of Bern, Switzerland
Robert Landsiedel, BASF, Germany

II-16b Inhalation toxicology – Non-nano
Michaela Aufderheide, Cultex, Germany
Samuel Constant, Epithelix, Switzerland

II-17   Ecotoxicology
Michelle R. Embry, HESI, USA
Stefan Scholz, UFZ, Germany